AFM41a: A Novel PAD2 Inhibitor for Sepsis Treatment—Efficacy and MechanismTao Dong(Xuzhou Medical College), Yongqing Li(University of Michigan)International Journal of Biological SciencesJanuary 1, 202410.7150/ijbs.97166Cited by 8SaveCiteExport RISWatch citationsRelated PapersPeptidylarginine deiminase 2 has potential as both a biomarker and therapeutic target of sepsis|JCI Insight|2020|60